← Leaderboards
York E Miller
University Of Colorado Denver
$6,348,289
Attributed
$7,483,792
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $797K · FY2006–22$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,483,792 · 9
By mechanism
P50$4,117,254 · 6
R01$2,271,006 · 1
P30$1,095,532 · 2
Top collaborators
- Moumita Ghosh6 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Paul A Bunn$21,859,370
- Raphael A. Nemenoff$15,000,654
- Robert Keith$1,373,712
- Timothy C Kennedy$560,508
- Karen Kelly$560,508
Others in their field
Top investigators on “Malignant Neoplasm Of Lung”
- David Heimbrook · Leidos Biomedical Research, Inc.$349,639,893
- Richard K. Wilson · Washington University$202,666,376
- Walter John Curran · Thomas Jefferson University$94,674,902
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$61,410,512
- Norman Wolmark · Nsabp Foundation, Inc.$54,610,124
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
Research focus
Malignant Neoplasm Of LungGrantLungBaseCancer RiskHigh RiskChemopreventionMalignant NeoplasmsResearch PersonnelProgramsInstitutionAnticancer ResearchCohortFundingReportingCareer DevelopmentValidationChemopreventive AgentColoradoClinical ResearchEarly DiagnosisTranslatingPre-ClinicalDysplasia
Grant awards (52)
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$305,715
R01 · FY2022 · CA
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$502,882
R01 · FY2021 · CA
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$500,948
R01 · FY2020 · CA
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$90,858
R01 · FY2019 · CA
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$427,989
R01 · FY2018 · CA
Predictors of Lung Nodule Malignancy$280,628
P50 · FY2018 · CA · contact PI
Career Development Program$76,113
P50 · FY2018 · CA · contact PI
Predictors of Lung Nodule Malignancy$6,134
P50 · FY2018 · CA · contact PI
Career Development Program$6,133
P50 · FY2018 · CA · contact PI
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$442,614
R01 · FY2017 · CA
Predictors of Lung Nodule Malignancy$284,665
P50 · FY2017 · CA · contact PI
Career Development Program$63,740
P50 · FY2017 · CA · contact PI
Predictors of Lung Nodule Malignancy$273,195
P50 · FY2016 · CA · contact PI
Career Development Program$67,438
P50 · FY2016 · CA · contact PI
LUNG, HEAD AND NECK CANCERS$36,906
P30 · FY2016 · CA · contact PI
Predictors of Lung Nodule Malignancy$276,068
P50 · FY2015 · CA · contact PI
Career Development Program$68,223
P50 · FY2015 · CA · contact PI
LUNG, HEAD AND NECK CANCERS$36,526
P30 · FY2015 · CA · contact PI
Predictors of Lung Nodule Malignancy$262,568
P50 · FY2014 · CA · contact PI
Career Development Program$67,628
P50 · FY2014 · CA · contact PI
LUNG, HEAD AND NECK CANCERS$33,430
P30 · FY2014 · CA · contact PI
The Biology of Pulmonary Premalignancy: Application to Risk Assessment and Chemop$123,331
P50 · FY2013 · CA · contact PI
Career Development Program$123,330
P50 · FY2013 · CA · contact PI
LUNG, HEAD AND NECK CANCERS$86,777
P30 · FY2013 · CA · contact PI
LUNG, HEAD AND NECK CANCERS$963
P30 · FY2013 · CA · contact PI
The Biology of Pulmonary Premalignancy: Application to Risk Assessment and Chemop$257,553
P50 · FY2012 · CA · contact PI
Career Development Program$102,416
P50 · FY2012 · CA · contact PI
LUNG, HEAD AND NECK CANCERS$36,987
P30 · FY2012 · CA · contact PI
The Biology of Pulmonary Premalignancy: Application to Risk Assessment and Chemop$252,397
P50 · FY2011 · CA · contact PI
Career Development Program$58,177
P50 · FY2011 · CA · contact PI
The Biology of Pulmonary Premalignancy: Application to Risk Assessment and Chemop$264,631
P50 · FY2010 · CA · contact PI
Career Development Program$62,613
P50 · FY2010 · CA · contact PI
TOBACCO RELATED MALIGNANCIES$24,736
P30 · FY2010 · CA · contact PI
The Biology of Pulmonary Premalignancy: Application to Risk Assessment and Chemop$281,959
P50 · FY2009 · CA · contact PI
Career Development Program$68,476
P50 · FY2009 · CA · contact PI
TOBACCO RELATED MALIGNANCIES$26,169
P30 · FY2009 · CA · contact PI
The Biology of Pulmonary Premalignancy: Application to Risk Assessment and Chemop$183,464
P50 · FY2008 · CA · contact PI
Career Development Program$45,866
P50 · FY2008 · CA · contact PI
TOBACCO RELATED MALIGNANCIES$24,612
P30 · FY2008 · CA · contact PI
TOBACCO RELATED MALIGNANCIES$23,936
P30 · FY2007 · CA · contact PI
TOBACCO RELATED MALIGNANCIES$13,278
P30 · FY2006 · CA · contact PI
Biomarkers of Neoplastic Change in Respiratory Epithelium$0
P50 · FY2003 · CA
TOBACCO RELATED MALIGNANCIES PROGRAM$250,404
P30 · FY2002 · CA
TOBACCO RELATED MALIGNANCIES PROGRAM$250,404
P30 · FY2002 · CA
NEUROPEPTIDE DEGRADATION AND PULMONARY CARCINOGENESIS$61,783
P50 · FY2002 · CA
TOBACCO RELATED MALIGNANCIES PROGRAM$250,404
P30 · FY2001 · CA
NEUROPEPTIDE DEGRADATION AND PULMONARY CARCINOGENESIS$61,783
P50 · FY2001 · CA
NEUROPEPTIDE DEGRADATION AND PULMONARY CARCINOGENESIS$61,783
P50 · FY2001 · CA
NEUROPEPTIDE DEGRADATION AND PULMONARY CARCINOGENESIS$61,783
P50 · FY2001 · CA
TOBACCO RELATED MALIGNANCIES PROGRAM$0
P30 · FY2001 · CA
NEUROPEPTIDE DEGRADATION AND PULMONARY CARCINOGENESIS$156,688
P50 · FY2000 · CA
NEUROPEPTIDE DEGRADATION AND PULMONARY CARCINOGENESIS$156,688
P50 · FY2000 · CA